Evidence map›Paper›PMID 41370805›Full record

ArticleThe New England journal of medicine2025

Molecular Evidence of Multiorgan Damage in Patients with Immune-Related Adverse Events.

Yuxuan Wang, Howard L Li, Chetan Bettegowda, Kenneth W Kinzler, Nickolas Papadopoulos, Mark Yarchoan, Bert Vogelstein

Abstract readLetter
In one paragraph

Article in The New England journal of medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yuxuan WangJohns Hopkins University School of Medicine, Baltimore.
Howard L LiJohns Hopkins University School of Medicine, Baltimore.
Chetan BettegowdaJohns Hopkins University School of Medicine, Baltimore.
Kenneth W KinzlerJohns Hopkins University School of Medicine, Baltimore.
Nickolas PapadopoulosJohns Hopkins University School of Medicine, Baltimore.
Mark YarchoanJohns Hopkins University School of Medicine, Baltimore.
Bert VogelsteinJohns Hopkins University School of Medicine, Baltimore.

Funding

Translational Research Central ServicesP30CA006973 · NCI · JOHNS HOPKINS UNIVERSITY · PI WILLIAM George NELSON · 1985 to 2026
$208.6M
Multi-analyte Approach for Earlier Detection of Cancers in Non Plasma BiofluidsU01CA230691 · NCI · JOHNS HOPKINS UNIVERSITY · PI Nishant Agrawal, CHETAN BETTEGOWDA · 2018 to 2026
$6.7M
Interrogating malignant gliomas using released tumor DNA in cerebrospinal fluidR37CA230400 · NCI · JOHNS HOPKINS UNIVERSITY · PI BETTEGOWDA, CHETAN · 2018 to 2024
$2.6M
MRgFUS-enabled non-invasive interrogation of malignant glioma via circulating tumor DNAR21NS113016 · NINDS · JOHNS HOPKINS UNIVERSITY · PI BETTEGOWDA, CHETAN, WOODWORTH, GRAEME F · 2019 to 2019
$454k
NCI NIH HHS P30 CA006973NCI NIH HHS R37 CA230400NCI NIH HHS U01 CA230691NIH HHS R21NS113016, RA37CA230400, U01CA230691NINDS NIH HHS R21 NS113016
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41370805
PMCPMC12698112

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.